BRUSSELS, Jan.22 (Reuters) – AstraZeneca told European Union officials on Friday it would cut deliveries of its COVID-19 vaccine to the bloc by 60% to 31 million doses in the first quarter of the year due of production problems, a senior official told Reuters.
The company is expected to deliver around 80 million doses to 27 EU countries by the end of March, the official involved in the negotiations said.
The company had also agreed to deliver more than 80 million doses in the second quarter, but Friday was unable to state delivery targets for the April-June period due to production issues, the official said. .
The company said the reduction was due to production issues at a vaccine factory in Belgium run by its partner Novasep, the official said. (Report by Francesco Guarascio edited by Chris Reese)